I'm LongbridgeAI, I can summarize articles.Oruka Therapeutics CMO Joana Goncalves sold 7,000 common shares on July 15, 2026, for approximately $601,227.73. The transaction involved exercising employee stock options and warrants at a cost of USD 6.84 to USD 7.8 per share, followed by sales at a weighted-average price of USD 84.37 to USD 87.25. Following this disposal, Goncalves holds 32,718 beneficially owned shares.
- Oruka Therapeutics Chief Medical Officer Joana Goncalves exercised 7,000 employee stock option and warrant shares on July 15, 2026 at USD 6.84 to USD 7.8. * Goncalves sold 7,000 shares on July 15 at weighted-average prices of about USD 84.37 to USD 87.25. * She ended the day with 32,718 shares of common stock beneficially owned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000073), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here